Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TB-LOAD BCG lung challenge biomarker study
PACTR202609673560343Phase 0Not yet recruiting
- Sponsor
- University of Cape Town Lung Institute
- Start
- Jul 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 0, open-label trial of bcg vaccine in Tuberculosis (TB) (3 arms), sponsored by University of Cape Town Lung Institute. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
bcg vaccine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on PACTR202609673560343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202609673560343.